SIRT2 and metabolic dysfunction-associated steatotic liver disease: An animal experiment found that SIRT2 improves NAFLD progression fed with high-fat diet (HFD) via the SIRT2-hepatocyte nuclear factor 4α (HNF4α) pathway [17].